Captrust Financial Advisors Abcam PLC Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $106,083 - $205,694	-8,406 Reduced 40.24%	12,482 $305,000
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $2,466 - $3,249	190 Added 0.92%	20,888 $281,000
Q4 2022 Feb 15, 2023	BUY	$13.92 - $17.0 $288,116 - $351,866	20,698 New	20,698 $322,000
Q1 2022 May 16, 2022	SELL	$15.5 - $23.89 $5,983 - $9,221	-386 Reduced 11.18%	3,068 $56,000
Q3 2021 Nov 16, 2021	SELL	$17.38 - $21.54 $13,243 - $16,413	-762 Reduced 18.07%	3,454 $70,000
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $62,742 - $75,107	3,397 Added 414.77%	4,216 $80,000
Q1 2021 May 17, 2021	BUY	$19.22 - $24.3 $15,741 - $19,901	819 New	819 $16,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.